Clinical Trials

70 enrolled

Extensive Small Cell Lung Cancer

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05189483 2024-02-07

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Sarcoma

NCT06227325 2024-01-26

Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression

27 enrolled

Stomach Neoplasms

NCT06197438 2024-01-09

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

36 enrolled

Stomach Neoplasms

NCT04989335 2023-11-28

Bisantrene Combination for Resistant AML

Other hematologic neoplasm

29 enrolled

Leukemia, Myeloid, Acute

NCT03446547 2023-11-14

ASTEROID

106 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06105658 2023-10-30

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

Other hematologic neoplasm

20 enrolled

Leukemia, Myeloid, Acute

NCT04074993 2023-09-28

Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays

Carcinoma, Non-Small-Cell Lung

NCT05800834 2023-09-28

MorphineGEL

106 enrolled

BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

78 enrolled

HER2 Positive Metastatic Breast Cancer

NCT04681287 2023-09-25

Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.

46 enrolled

HER2 Positive Metastatic Breast Cancer

NCT05751265 2023-06-22

Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

39 enrolled

Stomach Neoplasms

NCT05913570 2023-06-22

MSI-H/dMMR

22 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT04433156 2023-05-18

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

60 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT04293276 2023-05-06

DAP-Her-01

41 enrolled

Breast Neoplasms

NCT05799443 2023-04-05

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

23 enrolled

Colorectal Neoplasms

NCT05750290 2023-03-01

CKD-702 Plus Irinotecan in Gastric Cancer

Stomach Neoplasms

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

50 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT04077255 2022-11-30

EGFR-targeted Therapy for Gastric Cancer

19 enrolled

Adenocarcinoma of the Stomach

NCT04893252 2022-11-30

Vactosertib and Durvalumab in Gastric Cancer

55 enrolled

Stomach Neoplasms

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT05597527 2022-10-28

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Gynecologic

Ovarian Neoplasms

NCT05551767 2022-09-23

Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer

120 enrolled

Head & Neck

Head and Neck Neoplasms

NCT05545124 2022-09-19

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

32 enrolled

Carcinoma, Hepatocellular

NCT05314101 2022-08-23

TAS-102 Combined With Bevacizumab and Tislelizumab Third-line or Above in the Treatment of Liver Metastasis in Colorectal Cancer

25 enrolled

Colorectal Neoplasms

NCT05398861 2022-06-01

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

71 enrolled

HER-2 Negative Breast Cancer

NCT05385263 2022-05-26

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT02748707 2022-04-28

ERLO-XIB

64 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT05335460 2022-04-19

To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer

36 enrolled

Colonic Neoplasms

NCT05286164 2022-04-15

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

30 enrolled

Lymphoid

Lymphoma, B-Cell

NCT03062059 2022-04-14

The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence

134 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT04660097 2022-04-12

Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

120 enrolled

Small Cell Lung Carcinoma

NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

192 enrolled

Small Cell Lung Carcinoma

NCT01470716 2022-04-06

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

26 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03126799 2022-04-06

AvaTa

128 enrolled

EGFR Positive Non-small Cell Lung Cancer

NCT03262454 2022-04-06

Atezolizumab

Small Cell Lung Cancer Recurrent

NCT03612154 2022-04-06

Study of Lorlatinib in ROS1 Rearranged NSCLC

Carcinoma, Non-Small-Cell Lung

NCT03808480 2022-04-06

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05313906 2022-04-06

RC48 Plus AK105 and Cisplatin in Advanced Gastric Cancer

Advanced Gastric Carcinoma

NCT03113942 2022-03-31

SPACE

26 enrolled

High Grade Squamous Intra-epithelial Lesion (HSIL)

NCT05299255 2022-03-28

Utidelone in Third-line and Above Treatment of Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT05252091 2022-02-23

An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03939962 2022-01-26

Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma

60 enrolled

Stomach Neoplasms

NCT05207735 2022-01-26

SCRCA

73 enrolled

Cholangiocarcinoma

NCT05192681 2022-01-14

Tislelizumab as Cross-line Treatment for Advanced NSCLC

Advanced Non-small-cell Lung Cancer

NCT05007145 2021-12-21

REVO

92 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04901754 2021-12-08

CAMERA

38 enrolled

Small Cell Lung Carcinoma

NCT04764006 2021-11-04

Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study

10 enrolled

Advanced Colorectal Cancer

NCT04063683 2021-08-24

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

47 enrolled